Treatment Outcome of Acute Promyelocytic Leukemia with Modified Aida Protocol

Table 1

Demographic and baseline characteristics of the study population.

Characteristic	Total
	Median (range)	No. (%)
No. of patients		19 (100)
Age, year	40 (14–68)
15 or younger		1 (5)
16–60		17 (90)
61 or older		1 (5)
Gender
Male		10 (53)
Female		9 (47)
WBC count,×10^9/L	2.7 (0.4–49.0)
Less than 5		10 (52)
5–10		3 (16)
11–50		6 (32)
PB blast count,×10^9/L	60 (1–98)
Less than 30		3 (16)
30 or higher		16 (84)
Platelet count, ×10^9/L	13 (4–85)
Less than 40		15 (79)
40 or higher		4 (21)
Hemoglobin, g/dL	8.8 (5.0–10.6)
Less than 10		17 (90)
10 or higher		2 (10)
Creatinine, mg/dL	0.92 (0.59–1.47)
Less than 1.4		18 (95)
1.4 or higher		1 (5)
Coagulopathy
No		7 (37)
Yes		12 (63)
Morphologic subtype
Hypergranular		15 (79)
Microgranular		4 (21)
Relapse risk group
Low		3 (16)
Intermediate		11 (58)
High		5 (26)
PML/RARα isoform
BCR1/BCR2		10 (59)
BCR3		7 (41)
Not available		2